Providing leadership for the life sciences industry

New Study Looks at the Top Biotech Deals & IPOs of 2016

The RSA Group has published the latest of its Talent Equity® Reports, an analysis of biotech deals and IPOs in 2016.

A challenging year for the biotech sector, this report focuses on those CEOs and CFOs whose companies were outstanding in performing better than their peers in either IPOs or deal-making.   By comparing CEOs and CFOs across 10 separate measures, we look at the factors that have combined to enable them to stand out and succeed.

Executive Chairman, Nick Stephens said “….it’s the talent of the people that enables the wise use of investors’ funds to advance the science.  So what is it about the best of these company leaders that makes them so successful? What characteristics do they have that give them the edge over their competitors?”

Click here to read the full report


How the RSA group helps global Life Sciences find the best Life Sciences talent

Why choose RSA?

How the RSA group helps global life sciences find the best talent.